Results for tag: "Lucentis"

Lucentis is a drug used to treat a variety of cardiovascular diseases, including age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. It is a recombinant human monoclonal antibody fragment that binds to and inhibits the activity of vascular endothelial growth factor (VEGF). By blocking VEGF, Lucentis helps to reduce the growth of new blood vessels and reduce fluid leakage from existing vessels. Lucentis is approved for use in the United States, Europe, and other countries. It is typically administered as an intravitreal injection, and is available in both single-dose and multi-dose vials. The Lucentis market is highly competitive, with several major pharmaceutical companies offering the drug. These include Novartis, Genentech, Bayer, and Regeneron. Additionally, there are several generic versions of Lucentis available in some countries. Show Less Read more